Article Details
Retrieved on: 2022-11-28 20:07:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA accepted a new drug application for ritlecitinib from Pfizer Inc for individuals aged 12 years and older with alopecia areata.
Article found on: www.pharmacytimes.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here